[HTML][HTML] Advances in the management of diabetes mellitus: a focus on personalized medicine
FNU Sugandh, M Chandio, FNU Raveena, L Kumar… - Cureus, 2023 - ncbi.nlm.nih.gov
Diabetes mellitus poses a substantial global health challenge, necessitating innovative
approaches to improve patient outcomes. Conventional one-size-fits-all treatment strategies …
approaches to improve patient outcomes. Conventional one-size-fits-all treatment strategies …
[HTML][HTML] Microvascular dysfunction in heart failure with preserved ejection fraction: Pathophysiology, assessment, prevalence and prognosis
Heart failure with preserved ejection fraction (HFpEF) currently accounts for approximately
half of all new heart failure cases in the community. HFpEF is closely associated with chronic …
half of all new heart failure cases in the community. HFpEF is closely associated with chronic …
Adiponectin ameliorates placental injury in gestational diabetes mice by correcting fatty acid oxidation/peroxide imbalance-induced ferroptosis via restoration of CPT-1 …
Y Zheng, Q Hu, J Wu - Endocrine, 2022 - Springer
Purpose In gestational diabetes (GDM), abnormalities occur not only in glucose metabolism,
but also in lipid metabolism. Adiponectin (ADPN) plays an important role in the regulation of …
but also in lipid metabolism. Adiponectin (ADPN) plays an important role in the regulation of …
[HTML][HTML] Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential …
SS Shetty, A Krumerman - Cardiovascular diabetology, 2022 - Springer
Atrial fibrillation, the most common cardiac arrhythmia, results in substantial morbidity and
mortality related to its increased risks of stroke, heart failure, and impaired cognitive function …
mortality related to its increased risks of stroke, heart failure, and impaired cognitive function …
[HTML][HTML] Patient perspectives on the use of mobile apps to support heart failure management: A qualitative descriptive study
B Sivakumar, M Lemonde, M Stein, S Mak… - Plos one, 2023 - journals.plos.org
Background Adherence to diet and medical therapies are key to improving heart failure (HF)
outcomes; however, nonadherence is common. While mobile apps may be a promising way …
outcomes; however, nonadherence is common. While mobile apps may be a promising way …
[HTML][HTML] Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes
A Paasche, F Wiedmann, M Kraft, F Seibertz… - Basic Research in …, 2024 - Springer
In recent years, SGLT2 inhibitors have become an integral part of heart failure therapy, and
several mechanisms contributing to cardiorenal protection have been identified. In this …
several mechanisms contributing to cardiorenal protection have been identified. In this …
The impact of informal caregivers' preparedness on short-term outcomes of heart failure patients with insufficient self-care
M Cheng, C Zhu, Y Ge, Y Ke, Y Shi, Y Su… - European Journal of …, 2023 - academic.oup.com
Aims Even though self-care is essential in the long-term management of heart failure (HF), it
is often not performed adequately in HF populations. Mobilizing informal caregivers may be …
is often not performed adequately in HF populations. Mobilizing informal caregivers may be …
[HTML][HTML] Diabetes mellitus and heart failure
WZ Siao, YH Chen, CF Tsai, CM Lee… - Journal of Personalized …, 2022 - mdpi.com
The coexistence of diabetes mellitus (DM) and heart failure (HF) is frequent and is
associated with a higher risk of hospitalization for HF and all-cause and cardiovascular …
associated with a higher risk of hospitalization for HF and all-cause and cardiovascular …
[HTML][HTML] Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized …
Abstract Background In AFFIRM-AHF, treatment of iron deficiency with intravenous ferric
carboxymaltose (FCM) reduced the risk of heart failure (HF) hospitalization and improved …
carboxymaltose (FCM) reduced the risk of heart failure (HF) hospitalization and improved …
[HTML][HTML] Charlson Comorbidity Index is correlated with all-cause readmission within six months in patients with heart failure: a retrospective cohort study in China
S Sheng, F Xu, Y Zhang, Y Huang - BMC Cardiovascular Disorders, 2023 - Springer
Abstract Background Charlson Comorbidity Index (CCI) is positively associated with all-
cause readmission in patients with heart failure (HF) in western countries. However, there is …
cause readmission in patients with heart failure (HF) in western countries. However, there is …